AAAAAA
Results:
1-13
|
Results: 13
Authors:
BOCCA C
CAPUTO O
CAVALLI RB
GABRIEL L
MIGLIETTA A
GASCO MR
Citation: C. Bocca et al., PHAGOCYTIC UPTAKE OF FLUORESCENT STEALTH AND NON-STEALTH SOLID LIPID NANOPARTICLES, International journal of pharmaceutics, 175(2), 1998, pp. 185-193
Authors:
MIGLIETTA A
BOCCA C
RAMPA A
BISI A
GABRIEL L
Citation: A. Miglietta et al., GEIPARVARIN AND DERIVATIVES IN COMBINATION WITH TAXOL - EFFECT ON MICROTUBULAR ORGANIZATION IN 3T3 FIBROBLASTS, Anti-cancer drug design, 12(8), 1997, pp. 607-620
Authors:
HEDBERG CW
SAVARINO SJ
BESSER JM
PAULUS CJ
THELEN VM
MYERS LJ
CAMERON DN
BARRETT TJ
KAPER JB
OSTERHOLM MT
BOYER W
KAIRIS F
GABRIEL L
SOLER J
GYSWYT L
BRAY S
CARLSON R
HOOKER C
FASANO A
JARVIS K
MCDANIEL T
TORNIEPORTH N
Citation: Cw. Hedberg et al., AN OUTBREAK OF FOODBORNE ILLNESS CAUSED BY ESCHERICHIA-COLI O39-NM, AN AGENT NOT FITTING INTO THE EXISTING SCHEME FOR CLASSIFYING DIARRHEOGENIC ESCHERICHIA-COLI, The Journal of infectious diseases, 176(6), 1997, pp. 1625-1628
Authors:
ICHIHARA A
INSCHO EW
GABRIEL L
NAVAR LG
Citation: A. Ichihara et al., INFLUENCE OF NITRIC-OXIDE LEVELS ON AFFERENT ARTERIOLAR RESPONSES TO ANGIOTENSIN-II (ANGII), Journal of the American Society of Nephrology, 7(9), 1996, pp. 1567-1567
Authors:
MIGLIETTA A
BOCCA C
GADONI E
GABRIEL L
RAMPA A
BISI A
VALENTI P
DARE P
Citation: A. Miglietta et al., INTERACTION OF GEIPARVARIN AND RELATED-COMPOUNDS WITH PURIFIED MICROTUBULAR PROTEIN, Anti-cancer drug design, 11(1), 1996, pp. 35-48
Authors:
MIGLIETTA A
GADONI E
BOCCA C
GABRIEL L
Citation: A. Miglietta et al., PROOXIDANT AGENTS INDUCE MODIFICATIONS IN THE CYTOSKELETAL ORGANIZATION OF FIBROBLASTS, ATLA. Alternatives to laboratory animals, 24(4), 1996, pp. 557-565
Authors:
ZHI JG
MELIA AT
FUNK C
VIGERCHOUGNET A
HOPFGARTNER G
LAUSECKER B
WANG K
FULTON JS
GABRIEL L
MULLIGAN TE
Citation: Jg. Zhi et al., METABOLIC PROFILES OF MINIMALLY ABSORBED ORLISTAT IN OBESE OVERWEIGHTVOLUNTEERS/, Journal of clinical pharmacology, 36(11), 1996, pp. 1006-1011
Authors:
HERRMAN JPR
SURYAPRANATA H
GABRIEL L
DENHEIJER P
Citation: Jpr. Herrman et al., ARGATROBAN DURING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - RESULTS OF A DOSE-FINDING STUDY, Circulation, 94(8), 1996, pp. 2186-2186
Authors:
WANG K
DAVIS PP
CREWS T
GABRIEL L
EDOM RW
Citation: K. Wang et al., AN ELECTRON-CAPTURE DIENOPHILE DERIVATIZATION AGENT FOR INCREASING SENSITIVITY - DETERMINATION OF A VITAMIN-D ANALOG (RO-24-2090) IN PLASMASAMPLES WITH LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY, Analytical biochemistry, 243(1), 1996, pp. 28-40
Authors:
MIGLIETTA A
GADONI E
BUFFA M
OLIVERO A
GABRIEL L
Citation: A. Miglietta et al., INTERACTIONS BETWEEN CALVATIC ACID AND RELATED-COMPOUNDS WITH RAT-LIVER MICROSOMES, European journal of drug metabolism and pharmacokinetics, 20(4), 1995, pp. 249-254
Authors:
GADONI E
GABRIEL L
OLIVERO A
BOCCA C
MIGLIETTA A
Citation: E. Gadoni et al., ANTIMICROTUBULAR EFFECT OF CALVATIC ACID AND OF SOME RELATED-COMPOUNDS, Cell biochemistry and function, 13(4), 1995, pp. 231-238
Authors:
GIAMARELLOU H
KANELLAS D
KAVOUKLIS E
PETRIKKOS G
GABRIEL L
Citation: H. Giamarellou et al., COMPARATIVE PHARMACOKINETICS OF CIPROFLOXACIN, OFLOXACIN AND PEFLOXACIN IN HUMAN AQUEOUS-HUMOR, European journal of clinical microbiology & infectious diseases, 12(4), 1993, pp. 293-297
Authors:
GADONI E
OLIVERO A
MIGLIETTA A
BOCCA C
GABRIEL L
Citation: E. Gadoni et al., CYTOSKELETAL MODIFICATIONS INDUCED BY 4-HYDROXYNONENAL, Cytotechnology, 11, 1993, pp. 62-64
Risultati:
1-13
|